Know the whole bill.

Cash medicine costs: a dated starting point

The figures here concern branded weight and diabetes medicines, not every kind of peptide care.

On September 26, 2026, drug-company offers for people paying outside insurance mostly priced these medicines at $149 to $499 per month.

For some higher-strength tirzepatide (Zepbound) refills, those September 26, 2026 offers charge $699 if more than 45 days have passed since the last delivery.

The price changes with the named medicine, whether it is a pen, vial or tablet, and how strong it is.

An offer’s entry rules decide who can get it. Ask the drug company’s price service whether you meet those rules and what the next refill will cost.

Those prices cover the medicine; they do not set a Phoenix clinic’s total bill.

As of September 26, 2026, these offers use different meanings of a month: one product pack for some medicines, or a 28-day supply for others.

An introductory price can end

Under the September 26, 2026 offer, each of the first two monthly semaglutide (Ozempic) pen fills costs $199.

That starting price covers only the two lowest pen strengths. Only new patients qualify: they must live in the US, be aged 18 or older, and pay outside insurance.

Under that offer, insured people must not seek repayment from their plan or put the cost toward their deductible, the amount paid before insurance starts paying.

After those fills, that September 26, 2026 offer lists $349 or $499 per month, depending on strength.

As of September 26, 2026, many drug-company cash offers and savings cards promise their printed terms only through December 31, 2026.

Get the refill price and the offer’s end date in writing before comparing it with another quote.

Ask insurance about the exact use

Ask whether the plan pays for the named medicine for the health problem being treated, and what approval it needs first.

On September 26, 2026, Medicare’s regular drug cover, Part D, can pay for certain uses of these medicines beyond weight loss.

Examples include treating type 2 diabetes, lowering certain heart risks, or treating obstructive sleep apnea, where breathing is blocked during sleep.

Possible cover is not a promise of payment. Ask whether your plan lists the exact medicine and needs to approve payment before it is supplied.

Who can get the separate Medicare price?

The temporary Medicare GLP-1 Bridge program has a $50 monthly copay for certain weight-loss medicines, under its September 26, 2026 terms. Copay means your share of the bill; this program runs through December 31, 2027.

This program works outside regular Part D drug cover.

Under the September 26, 2026 entry rules, you must be at least 18. You need either a separate drug plan under Part D or a qualifying Medicare Advantage plan that arranges care and includes drug cover.

Some other Medicare plan types are excluded unless you also have a separate Part D drug plan. Ask your plan to confirm its type.

The health test uses body mass index (BMI), a weight-for-height number. It uses your health when you first began this kind of medicine.

The weight test is met with a BMI of at least 35. At lower BMI values, a health problem from the program’s list is also required.

With a BMI of at least 30, the program requires one of its listed problems. These are a specified form of heart failure, certain high blood pressure despite two medicines, or kidney disease recorded as stage 3a or later.

The threshold for this list is a BMI of at least 27. The listed problems are pre-diabetes, a past stroke or heart attack, or artery disease with symptoms in the arms or legs.

Ask the person writing your prescription to compare your recorded weight, height, exact heart or kidney diagnoses and blood-pressure readings with the linked Medicare entry table.

People with type 2 diabetes or moderate to severe obstructive sleep apnea use the regular Part D route instead. Certain advanced liver disease and prescriptions for heart-risk reduction also go through Part D.

The liver exception covers the particular fatty-liver illness and degree of scarring named in the entry table. A diagnosis of fatty liver, by itself, does not exclude you from the Bridge.

You cannot enter the Bridge in 2026 if Part D has already paid for this kind of medicine during 2026. As of September 26, 2026, the previous-coverage rule for 2027 has not been set.

The program requires a prescription and approval of the request before payment. The medicine must be prescribed with ongoing changes to eating and physical activity.

Under the September 26, 2026 terms, the Bridge’s $50 payment does not count toward regular Part D’s yearly limit on your own spending.

The Bridge payment is separate from your regular drug-plan bill. Ask which route will pay for your prescription before counting on this price.

Get these lines on the quote

• The first visit and later visits, or the recurring membership fee.
• The exact medicine, form and supply covered by the price.
• Any lab tests, separate ordering fee and delivery charge.
• The later refill price, cancellation terms and any prepayment.

Compare like with like: the same product, the same supply and the same included services.